Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01430416
Title Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Age Groups: adult
Covered Countries USA | NLD | GBR | FRA

Facility Status City State Zip Country Details
Dana Farber Cancer Institute DFCI - Brookline Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering MSKCC 4 New York New York 10017 United States Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site London SW3 6JJ United Kingdom Details
*Shaded cells indicate that there was no data available from for the field